ETC
AURA icon

Exchange Traded Concepts’s Aura Biosciences AURA Stock Holding History

Exchange Traded Concepts’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,895
Closed -$99K – 1412
2025
Q1 		$99K Buy
16,895
+98
+0.6% +$741 ﹤0.01% 1166
2024
Q4 		$138K Hold
16,797
– – ﹤0.01% 1080
2024
Q3 		$150K Sell
16,797
-12,334
-42% -$106K ﹤0.01% 1070
2024
Q2 		$220K Sell
29,131
-9,064
-24% -$66.4K 0.01% 863
2024
Q1 		$300K Buy
38,195
+23,296
+156% +$193K 0.01% 795
2023
Q4 		$132K Buy
14,899
+3,778
+34% +$32K ﹤0.01% 847
2023
Q3 		$99.8K Sell
11,121
-305
-3% -$3.28K ﹤0.01% 897
2023
Q2 		$141K Buy
+11,426
New +$122K ﹤0.01% 861

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Exchange Traded Concepts's AURA Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Aura Biosciences (AURA) in Q2 2025, closing a stake of 16,895 shares — an estimated $99K sold.

Exchange Traded Concepts first reported a position in AURA in Q2 2023 and held it in 8 quarters. The position peaked at $300K in Q1 2024. 104 funds tracked by Wall St. Rank hold AURA as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Aura Biosciences position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 16,895 Aura Biosciences shares in Q2 2025, an estimated $99K.
  • Exchange Traded Concepts first reported a position in Aura Biosciences in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Aura Biosciences position peaked at $300K in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.